LOS ANGELES, May 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have ...
NEW YORK, May 7, 2026 /PRNewswire/ -- ...
Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.
Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell ...
Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged ...
Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected ...
Detailed price information for Fortrea Holdings Inc (FTRE-Q) from The Globe and Mail including charting and trades.
The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. . Shareholders who purchased shares of ...
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Medpace ...
Clinical research company IQVIA (NYSE: IQV) will be reporting results this Tuesday before the bell. Here’s what you need to ...
Is MEDP a good stock to buy? We came across a bullish thesis on Medpace Holdings, Inc. on The Atomic Moat’s Substack by Rob H ...
Being part of clinical trials can be a profitable way to help advance research, but there are many trade-offs to consider.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results